Moreover, CXCL3 has been shown to be enriched in the plasma of colon cancer patients, with elevated levels correlating with aggressive clinical features such as advanced stage, poor differentiation, and lymph node metastasis [25]. Here, CXCL3 is linked to colonic neoplasm.